Filter registries KELA purch., KELA reimb.
Check pre-conditions None
Include endpoints
Check conditions None
Apply sex-specific rule None
RX_NSAID
Extra metadata
List of similar endpoints to
Anti-inflammatory and antirheumatic products, non-steroids
based on the number of shared cases.
Broader endpoints:
None
Narrower endpoints:
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 216855 | 127447 | 89408 |
| Unadjusted prevalence (%) | 83.40 | 86.73 | 79.07 |
| Mean age at first event (years) | 41.73 | 39.75 | 44.55 |
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | 0.02 | 0.80 [0.73, 0.87] | 3.7e-7 | 14846 |
| 15 years | 0.01 | 0.85 [0.79, 0.92] | 3.2e-5 | 9405 |
| 5 years | 0.00 | 0.93 [0.85, 1.01] | 7.8e-2 | 1938 |
| 1 year | 0.00 | 0.93 [0.79, 1.10] | 3.8e-1 | 342 |
Index endpoint: RX_NSAID – Anti-inflammatory and antirheumatic products, non-steroids
GWS hits:
before Anti-inflammatory and antirheumatic products, non-steroids
after Anti-inflammatory and antirheumatic products, non-steroids
Loading survival analyses plot
Loading survival analyses table